PubRank

Bruno Gander

Author PubWeight™ 47.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005 2.17
2 Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004 1.30
3 Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst 2007 1.29
4 TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 2008 1.26
5 Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005 1.22
6 Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release 2010 1.20
7 Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials 2007 1.17
8 Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Vaccine 2003 1.14
9 Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 2003 1.12
10 Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discov Today 2011 1.10
11 Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripher Nerv Syst 2010 1.07
12 Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res 2009 1.05
13 Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine 2005 1.05
14 In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci 2002 1.01
15 Growth factor delivery systems and repair strategies for damaged peripheral nerves. J Control Release 2011 0.99
16 Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF. J Control Release 2009 0.98
17 Lympho-geographical concepts in vaccine delivery. J Control Release 2010 0.97
18 Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target 2009 0.97
19 Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother 2005 0.92
20 Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med 2005 0.89
21 Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int J Pharm 2010 0.89
22 Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. J Antimicrob Chemother 2004 0.88
23 Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods 2004 0.88
24 Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. Biomaterials 2010 0.87
25 Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J Control Release 2008 0.86
26 Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm 2008 0.86
27 Ultrasonic atomisation into reduced pressure atmosphere--envisaging aseptic spray-drying for microencapsulation. J Control Release 2004 0.86
28 One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J Control Release 2005 0.85
29 The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials 2006 0.85
30 Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production. Ultrason Sonochem 2004 0.85
31 Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs. Eur J Neurosci 2007 0.84
32 In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation. Vaccine 2004 0.83
33 A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharm Res 2007 0.82
34 Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Control Release 2004 0.82
35 Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice. J Control Release 2005 0.82
36 Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res 2005 0.81
37 Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. Eur J Pharm Biopharm 2011 0.81
38 Development of synthetic biodegradable microparticulate vaccines: a roller coaster story. Expert Rev Vaccines 2007 0.81
39 Hydrogel nerve conduits produced from alginate/chitosan complexes. J Biomed Mater Res A 2007 0.80
40 On technological and immunological benefits of multivalent single-injection microsphere vaccines. Pharm Res 2002 0.80
41 An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J Pharm Sci 2003 0.80
42 Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant. Int J Cancer 2011 0.79
43 Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm 2013 0.79
44 Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. J Control Release 2004 0.78
45 Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep. Eur J Pharm Biopharm 2013 0.77
46 Nerve conduit scaffolds for discrete delivery of two neurotrophic factors. Eur J Pharm Biopharm 2013 0.77
47 Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen. J Control Release 2011 0.76
48 Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication. Int J Pharm 2008 0.76
49 Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells. Pharm Res 2004 0.76
50 Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction. Eur J Pharm Biopharm 2005 0.76
51 Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives. J Pharm Pharmacol 2004 0.75
52 Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy. Drug Dev Ind Pharm 2012 0.75
53 Foreword - In honor of Prof. em. Dr. Hans Peter Merkle on the occasion of his 70th birthday. Eur J Pharm Biopharm 2013 0.75
54 Development of a novel casein-protamine based microparticles for early feeding of fish larvae: in vitro evaluation. J Microencapsul 2007 0.75